These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11022795)

  • 21. A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia.
    Höffken G; Barth J; Rubinstein E; Beckmann H;
    Infection; 2007 Dec; 35(6):414-20. PubMed ID: 18034211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.
    Wessels F; Anderson AN; Ebrahim O
    S Afr Med J; 1998 Mar; 88(3):251-5. PubMed ID: 9608289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
    Lim TK
    Singapore Med J; 1997 Mar; 38(3):139. PubMed ID: 9269388
    [No Abstract]   [Full Text] [Related]  

  • 24. A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy.
    Siegel RE; Halpern NA; Almenoff PL; Lee A; Cashin R; Greene JG
    Chest; 1996 Oct; 110(4):965-71. PubMed ID: 8874253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.
    Mathur S; Fuchs A; Bielicki J; Van Den Anker J; Sharland M
    Paediatr Int Child Health; 2018 Nov; 38(sup1):S66-S75. PubMed ID: 29790844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the use of cefuroxime and cefuroxime axetil in an intravenous-oral stepdown program.
    Malfair SC; Frighetto L; Nickoloff DM; Martinusen SM; Jewesson PJ
    Ann Pharmacother; 1996 Apr; 30(4):337-42. PubMed ID: 8729884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
    Schleupner CJ; Anthony WC; Tan J; File TM; Lifland P; Craig W; Vogelman B
    Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of community-acquired lower respiratory tract infections with oral cefuroxime axetil.
    Limson BM; Garvez MD
    Clin Ther; 1990; 12(5):436-9. PubMed ID: 2268866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IV Penicillin G is as effective as IV cefuroxime in treating community-acquired pneumonia in children.
    Amarilyo G; Glatstein M; Alper A; Scolnik D; Lavie M; Schneebaum N; Grisaru-Soen G; Assia A; Ben-Sira L; Reif S
    Am J Ther; 2014; 21(2):81-4. PubMed ID: 22407197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia.
    Paladino JA; Gudgel LD; Forrest A; Niederman MS
    Chest; 2002 Oct; 122(4):1271-9. PubMed ID: 12377852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Children with pneumonia: how do they present and how are they managed?
    Clark JE; Hammal D; Spencer D; Hampton F
    Arch Dis Child; 2007 May; 92(5):394-8. PubMed ID: 17261579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential therapy with cefuroxime and cefuroxime-axetil for community-acquired lower respiratory tract infection in the oldest old.
    Flamaing J; Knockaert D; Meijers B; Verhaegen J; Peetermans WE
    Aging Clin Exp Res; 2008 Feb; 20(1):81-6. PubMed ID: 18283233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefuroxime therapy for pneumonia in infants and children.
    Nelson JD; Kusmiesz H; Shelton S
    Pediatr Infect Dis; 1982; 1(3):159-63. PubMed ID: 6755404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia.
    Marrie TJ
    Chemotherapy; 2004; 50 Suppl 1():11-5. PubMed ID: 15319549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.
    Johnson PA; Rodriguez HP; Wazen JJ; Huck W; Shan M; Tosiello R; Heyd A; Echols RM
    J Otolaryngol; 1999 Feb; 28(1):3-12. PubMed ID: 10077777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of cefaclor and cefuroxime axetil in the treatment of acute otitis media with effusion in children who failed amoxicillin therapy.
    Turik MA; Johns D
    J Chemother; 1998 Aug; 10(4):306-12. PubMed ID: 9720470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of cefuroxime (Zinacef) in bacterial pneumonias in children].
    Popa MI
    Bacteriol Virusol Parazitol Epidemiol; 1995; 40(3-4):220. PubMed ID: 8640004
    [No Abstract]   [Full Text] [Related]  

  • 38. Are oral cefuroxime axetil, cefixime and cefditoren pivoxil adequate to treat uncomplicated acute pyelonephritis after switching from intravenous therapy? A pharmacokinetic/pharmacodynamic perspective.
    Rodríguez-Gascón A; Aguirre-Quiñonero A; Canut-Blasco A
    Enferm Infecc Microbiol Clin (Engl Ed); 2020; 38(7):306-311. PubMed ID: 32085928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community -acquired pneumonia in children.
    Aurangzeb B; Hameed A
    J Coll Physicians Surg Pak; 2003 Dec; 13(12):704-7. PubMed ID: 15569557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical efficacy of oral clarithromycin monotherapy in patients with mild or moderate community-acquired pneumonia].
    Fujiki R; Rikimaru T; Aizawa H; Kawayama T
    Jpn J Antibiot; 2003 Dec; 56(6):712-8. PubMed ID: 15007880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.